Onzima Ventures Share Discussion Threads

[keya5000] 17/6/2016 16:40

Very strange, hard to buy any all afternoon and then they drop it on two 50k sells like that.

Oh well bring on next week.

[luminoso] 17/6/2016 16:26

Hmm. i don't like inexplicable drops in the share price at the last minute on a Friday. Just MM games, I hope !!

[someuwin] 17/6/2016 15:52

Agree - 2p+ next week.

The valuation here is just way too low.

[gimmetheloot] 17/6/2016 14:45

Superb article from April.
Can't remember reading this at the time but gives a great overview of N4's potential.

[keya5000] 17/6/2016 14:05

Next week could likely see us break through 2p. We seem to have consolidated nicely with volume in this range and any positive news via RNS or presentations etc will push us much higher.

[someuwin] 17/6/2016 14:02

You were right keya.

[someuwin] 17/6/2016 13:57

Can buy £1k but can't get £2k

[keya5000] 17/6/2016 13:57

Trades very strange this one.

Surely they will have to let it go soon.

[luminoso] 17/6/2016 13:11

Strange how the price dips again before a couple of sizeable purchases, like it did this morning !

[someuwin] 17/6/2016 11:39

Better hurry for tickets if you want to meet ONZ / N4 Pharma + others

Momentous Events ‏@Momentous_UK · 20 minutes ago

Ticket numbers for the FREE Investor event at The O2 ABO VIP Lounge have now smashed through the 200 barrier. Not many left now.

[someuwin] 17/6/2016 11:14

It's not just N4 CEO Nigel Theobald who who has previous experience of successfully developing new pharma companies.

The other main player at N4 Paul Titley was founder of R5 pharmaceuticals...

"Over 40 years’ experience of pharmaceutical dosage form development. Paul led the pharmaceutical development of major products at Wellcome including Zovirax and Retrovir. Has spells at Quintiles and Encap before Paul became CEO of R5 pharmaceuticals which he grew into a leading formulation services company which was acquired by Aesica in 2010"

...I'm sure that together they will grow N4 Pharma to be an even bigger success story.

[fido] 17/6/2016 10:33

Walloon3,
I was being generous in attributing you half a wit.

[walloon3] 17/6/2016 10:25

better half a wit than none eh old bean!

[luminoso] 17/6/2016 08:43

Was too difficult buying online yesterday but managed a top up at 1.64 today thanks to a few sells.

[someuwin] 17/6/2016 08:06

Tick up on a couple of buys.

[jakleeds] 16/6/2016 15:49

Paying over the quoted offer now for just 100,000 shares ...

[someuwin] 16/6/2016 14:32

I am convinced that there is a total mismatch between the ONZ price and the inherant value of their 49% N4 holding.

I am expecting this to correct with some form of corporate deal - hopefully at a much higher price.

RTO? N4 IPO? ONZ funding at big premium to buy more N4? who knows - but at these levels I am contuining to load up with ONZ.

[keya5000] 16/6/2016 13:33

Think you can safely say the overhang that seemed to be here is now cleared.

[someuwin] 16/6/2016 13:22

Nice one jak.

This will be over 2p soon - and I don't think it will be coming down again.

[jakleeds] 16/6/2016 13:19

I got a few more earlier

[someuwin] 16/6/2016 13:18

Naturally, you can't buy any.

[keya5000] 16/6/2016 13:07

Nigel told me earlier this week he had not left his last company for no reason. He left to 'create something bigger and better at N4'.

Think his last company peaked at £130m mcap.

N4 valuation based on our mcap minus liquid assets cash=£2m today.

We need to be adding a zero on that figure now for some hope value.

[simonparker5] 16/6/2016 12:52

Thanks for sharing someuwin, he does seem very positive and driven.
Adds even more evidence that we are very undervalued and as has been said, if the market gets a sniff that some sort of partnership or even collaboration deal is going on then 10p or more must be a possibility.

[keya5000] 16/6/2016 12:48

someuwin, when you look at other early stage bio-techs on AIm and their mcaps this is crazy cheap at the moment.

The strong buying today is encouraging also.